Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision history shows Revision: v3.5.4 was added and Revision: v3.5.3 removed. This indicates a small, non-substantive update to the page's revision metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer revision indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a documentation/build version change rather than an adjustment to the study details.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a minor update to the page without altering core content.SummaryDifference0.1%

- Check66 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; there are no visible changes to the study details, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

- Check102 days agoChange DetectedAdded gastric cancer as a condition and introduced the Genetic and Rare Diseases Information Center as a resources link; updated the page revision to v3.4.2 and removed the government funding status notice.SummaryDifference0.6%

Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.